Applied Genetic Technologies reported $-13481000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Alimera Sciences ALIM:US $ -1937000 2.21M
Applied Genetic Technologies AGTC:US $ -13481000 4.8M
Avrobio Inc AVRO:US $ -29418000 1.46M
Biogen BIIB:US $ 940.9M 409.4M
Bluebird Bio BLUE:US $ -100761000 19.58M
Celldex Therapeutics CLDX:US $ -23257000 2.92M
Cti Biopharma CTIC:US $ -35100000 275K
Gilead Sciences GILD:US $ 2029M 868M
Insmed INSM:US $ -100938000 513K
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
Life Technologies LIFE:US $ -12378000 3.74M
Ophthotech OPHT:US $ -49753000 15.08M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Ultragenyx Pharmaceutical RARE:US $ -141593000 4.96M